Clinical evaluation of the Roche Elecsys® CMV IgG Avidity assay

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 8, 2014, Pages 1365-1369

  Vauloup Fellous, C ^a,b   Lazzarotto, T ^c   Revello, M G ^d   Grangeot Keros, L ^e  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOASSAY ANALYZER; IMMUNOGLOBULIN PRODUCTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ANTIBODY AFFINITY; BLOOD; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTIONS; EVALUATION STUDY; FEMALE; IMMUNOLOGY; MULTICENTER STUDY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SENSITIVITY AND SPECIFICITY;

EID: 84903821536     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2080-4     Document Type: Article

References (18)

1. Adler SP (2011) Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol 2011:1-9
2. Revello MG, Gerna G (2008) Maternal, fetal and neonatal diagnosis of congenital human cytomegalovirus infection. Expert Opin Med Diagn 2:547-563
3. Enders G, Daiminger A, Bäder U, Exler S, Enders M (2011) Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 52:244-246
4. Picone O, Vauloup-Fellous C, Cordier AG, Guitton S, Senat MV, Fuchs F, Ayoubi JM, Grangeot Keros L, Benachi A (2013) A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diagn 33:751-758
5. Bodéus M, Hubinont C, Goubau P (1999) Increased risk of cytomegalovirus transmission in utero during late gestation. Obstet Gynecol 93:658-660 (Pubitemid 29190658)
6. Wang C, Zhang X, Bialek S, Cannon MJ (2011) Attribution of congenital cytomegalovirus infection to primary versus nonprimary maternal infection. Clin Infect Dis 52:e11-e13
7. Munro SC, Hall B, Whybin LR, Leader L, Robertson P, Maine GT, Rawlinson WD (2005) Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol 43:4713-4718 (Pubitemid 41298268)
8. Eggers M, Bäder U, Enders G (2000) Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy. J Med Virol 60:324-330 (Pubitemid 30054287)
9. Lazzarotto T, Spezzacatena P, Pradelli P, Abate DA, Varani S, Landini MP (1997) Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin Diagn Lab Immunol 4:469-473 (Pubitemid 27321782)
10. Revello MG, Genini E, Gorini G, Klersy C, Piralla A, Gerna G (2010) Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. J Clin Virol 48:255-259
11. Revello MG, Gorini G, Gerna G (2004) Clinical evaluation of a chemiluminescence immunoassay for determination of immunoglobulin g avidity to human cytomegalovirus. Clin Diagn Lab Immunol 11:801-805 (Pubitemid 38944011)
12. Furione M, Rognoni V, Cabano E, Baldanti F (2012) Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay. J Clin Virol 55:317-322
13. Lazzarotto T, Ripalti A, Bergamini G, Battista MC, Spezzacatena P, Campanini F, Pradelli P, Varani S, Gabrielli L, Maine GT, Landini MP (1998) Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM. J Clin Microbiol 36:3337-3341 (Pubitemid 28476189)
14. Elecsys CMV IgG Avidity assay package insert (2012) Roche Diagnostics GmbH, Mannheim, Germany
15. Lagrou K, Bodeus M, van Ranst M, Goubau P (2009) Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays. J Clin Microbiol 47:1695-1699
16. Bodéus M, Beulné D, Goubau P (2001) Ability of three IgG-avidity assays to exclude recent cytomegalovirus infection. Eur J Clin Microbiol Infect Dis 20:248-252 (Pubitemid 32477242)
17. Lefevre-Pettazzoni M, Le Cam S, Wallon M, Peyron F (2006) Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women. Eur J Clin Microbiol Infect Dis 25:687-693 (Pubitemid 44806776)
18. Vauloup-Fellous C, Berth M, Heskia F, Dugua J-M, Grangeot-Keros L (2013) Re-evaluation of the VIDAS(®) cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation. J Clin Virol 56:118-123